Related Experiment Video
Updated: Jun 7, 2026

Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine (DOPA) and Its Application to Protein Conjugation
Published on: August 24, 2018
Bioconversion of L-tyrosine to L-DOPA by a novel bacterium Bacillus sp. JPJ
Shripad N Surwase1, Jyoti P Jadhav
1Department of Microbiology, Shivaji University, Vidyanagar, Kolhapur, 416004, India. shripad.surwase@gmail.com
Abstract:
L-DOPA is an amino acid derivative and most potent drug used against Parkinson's disease, generally obtained from Mucuna pruriens seeds. In present communication, we have studied the in vitro production of L-DOPA from L-tyrosine by novel bacterium Bacillus sp. JPJ. This bacterium produced 99.4% of L-DOPA from L-tyrosine in buffer (pH 8) containing 1 mg ml(-1) cell mass incubated at 40°C for 60 min. The combination of CuSO(4) and L-ascorbic acid showed the inducing effect at concentrations of 0.06 and 0.04 mg ml(-1), respectively. The activated charcoal 2 mg ml(-1) was essential for maximum bioconversion of L-tyrosine to L-DOPA and the crude tyrosinase activity was 2.7 U mg(-1) of tyrosinase. Kinetic studies showed significant values of Y (p/s) (0.994), Q (s) (0.500) and q (s) (0.994) after optimization of the process. The production of L-DOPA was confirmed by analytical techniques such as HPTLC, HPLC and GC-MS. This is the first report on rapid and efficient production of L-DOPA from L-tyrosine by bacterial source which is more effective than the plant, fungal and yeast systems.
Insights
Researchers developed a novel bacterial method for producing L-DOPA, a key Parkinson's disease drug, from L-tyrosine. This efficient bioconversion by Bacillus sp. JPJ offers a superior alternative to traditional plant-based extraction methods.
Area of Science:
- Biotechnology
- Biochemistry
- Microbiology
Background:
- L-DOPA is a crucial drug for Parkinson's disease treatment.
- Currently, L-DOPA is primarily sourced from Mucuna pruriens seeds.
- Existing production methods face limitations in efficiency and scalability.
Purpose of the Study:
- To investigate the in vitro production of L-DOPA from L-tyrosine using a novel bacterial strain.
- To optimize conditions for efficient L-DOPA bioconversion.
- To establish a rapid and effective bacterial-based L-DOPA production system.
Main Methods:
- Utilized Bacillus sp. JPJ for in vitro L-DOPA production from L-tyrosine.
- Optimized reaction parameters including pH, temperature, cell mass concentration, and incubation time.
- Investigated the effect of CuSO(4), L-ascorbic acid, and activated charcoal as enhancers.
- Confirmed L-DOPA production using HPTLC, HPLC, and GC-MS analytical techniques.
Main Results:
- Achieved 99.4% conversion of L-tyrosine to L-DOPA under optimized conditions.
- Identified optimal conditions: pH 8, 40°C, 1 mg/ml cell mass, 60 min incubation.
- Determined optimal concentrations for CuSO(4) (0.06 mg/ml) and L-ascorbic acid (0.04 mg/ml).
- Activated charcoal (2 mg/ml) was essential for maximum bioconversion, yielding 2.7 U/mg tyrosinase activity.
Conclusions:
- Demonstrated rapid and highly efficient in vitro L-DOPA production from L-tyrosine using Bacillus sp. JPJ.
- This bacterial bioconversion method is more effective than current plant, fungal, and yeast systems.
- Presents a promising and scalable alternative for L-DOPA synthesis.
Related Concept Videos
Biosynthesis in Bacteria
Bacterial Transformation
Bacterial Transformation
Microbial Fermentation
Drugs Affecting Neurotransmitter Synthesis
Production of Antibiotics
